| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical Development of Src Tyrosine Kinase Inhibitors in Lung Cancer
|
Lee, David Lee
|
|
2006
|
7 |
6 |
p. 381-384
4 p.
|
article
|
| 2 |
Decreased Fragile Histidine Triad Gene Messenger RNA Expression in Lung Cancer
|
Sasaki, Hidefumi
|
|
2006
|
7 |
6 |
p. 412-416
5 p.
|
article
|
| 3 |
Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non-Small-Cell Lung Cancer
|
Reck, Martin
|
|
2006
|
7 |
6 |
p. 406-411
6 p.
|
article
|
| 4 |
Highlights From: 97th Annual Meeting of the American Association for Cancer Research; Washington, DC, April 2006
|
Ranganathan, Aarati
|
|
2006
|
7 |
6 |
p. 373-377
5 p.
|
article
|
| 5 |
Pharmacodynamic Separation of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy in Non–Small-Cell Lung Cancer
|
Davies, Angela M.
|
|
2006
|
7 |
6 |
p. 385-388
4 p.
|
article
|
| 6 |
PIONEER: A Phase III Randomized Trial of Paclitaxel Poliglumex Versus Paclitaxel in Chemotherapy-Naive Women with Advanced-Stage Non-Small-Cell Lung Cancer and Performance Status of 2
|
Albain, Kathy S.
|
|
2006
|
7 |
6 |
p. 417-419
3 p.
|
article
|
| 7 |
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer
|
Ghio, Paulo
|
|
2006
|
7 |
6 |
p. 395-400
6 p.
|
article
|
| 8 |
Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer
|
Tibaldi, Carmelo
|
|
2006
|
7 |
6 |
p. 401-405
5 p.
|
article
|
| 9 |
Selected Clinical Trials in Lung Cancer
|
|
|
2006
|
7 |
6 |
p. 420-
1 p.
|
article
|
| 10 |
Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21
|
Clark, Gary M.
|
|
2006
|
7 |
6 |
p. 389-394
6 p.
|
article
|
Journal description